<DOC>
	<DOCNO>NCT01945346</DOCNO>
	<brief_summary>This exploratory study evaluate new anti-inflammatory drug , PRX167700 , subject painful osteoarthritis knee . The purpose study investigate PRX167700 improve pain osteoarthritis knee , assess safety tolerability . The study also investigate PRX167700 pharmacokinetics .</brief_summary>
	<brief_title>An Exploratory Study PRX167700 Patients With Knee Osteoarthritis</brief_title>
	<detailed_description>Up 74 subject receive either PRX167700 placebo ( dummy treatment ) 15 day . Subjects need stop take usual pain reliever medicine least 7 day start treatment induce 'flare ' osteoarthritis symptom ( allow continue use paracetamol immediate pain relief need throughout trial ) . The effect PRX167700 placebo knee pain assess exercise Days 1 , 3 , 7 14 . On Day 15 , blood sample collect measure level PRX167700 ass activity .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Body Mass Index ( BMI ) 20 35 kg/m2 , inclusive . Symptomatic primary OA knee least 3 month prior Screening accord American College Rheumatology ( ACR ) criterion . Diagnosis OA knee base ACR criterion Xray confirmation ( KellgrenLawrence Xray grade â‰¥2 ) target knee joint . Use analgesics treatment knee OA least 4 7 day 4 week precede Screening visit . Willing able discontinue current analgesic therapy , include counter ( OTC ) pain medication topical analgesic OA pain , period begin Screening continue entire duration study . Able walk 100 metre flat course without rest unaided . A selfrated Pain Intensity score target knee joint 3 8 , inclusive , immediately time 100 metre walk flat course . Able provide write informed consent participate study , opinion investigator , able read , comprehend record information require protocol . Secondary cause arthritis knee , disease spine low extremity joint ( OA ) , knee pain characteristic neuropathic pain . Lower extremity surgery ( include arthroscopy ) within 6 month prior Screening schedule surgery kind study . Significant injury target knee joint within 12 month prior Screening . Known history hypersensitivity intolerance paracetamol lactose . Oral corticosteroid within 1 month Screening Therapeutic injection target knee joint within previous 3 month . Intraarticular corticosteroid injection site within 1 month intramuscular corticosteroid injection within 3 month . Start change dose regimen therapy OA within 3 month Screening . Start change establish physiotherapy programme within 2 week Screening ( Visit 1 ) course study . An established physiotherapy program may continue throughout study period unchanged frequency intensity . Any significant clinical biological abnormality ( related OA ) would preclude safe participation study .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>PRX167700</keyword>
	<keyword>Osteoarthritis</keyword>
</DOC>